Viatris Inc.
VTRS Healthcare Drug Manufacturers Specialty & Generic
Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.
Follow VTRS
Viatris Inc. (VTRS) Operating margin
Viatris Inc.'s operating margin over the twelve months to 30 June 2026 was −0.59%, up 18.0 percentage points from fiscal 2025 (−18.6%). Over the past ten years it has ranged from −18.6% (fiscal 2025) to 15.5% (fiscal 2015) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −18.6% | (18.69) |
| FY2024 | 0.07% | (4.90) |
| FY2023 | 4.97% | (4.96) |
| FY2022 | 9.93% | 10.12 |
| FY2021 | −0.19% | 1.57 |
| FY2020 | −1.76% | (7.98) |
| FY2019 | 6.22% | (1.70) |
| FY2018 | 7.92% | (4.15) |
| FY2017 | 12.1% | 5.76 |
| FY2016 | 6.31% | (9.18) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 0.17% | 2.44 |
| Mar 2026 | −2.27% | 2.93 |
| Dec 2025 | −5.20% | (9.96) |
| Sep 2025 | 4.76% | (1.74) |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| UTHR United Therapeutics Corporation compare | 44.4% |
| ZTS Zoetis Inc. compare | 37.1% |
| NBIX Neurocrine Biosciences, Inc. compare | 23.6% |
| HLN Haleon PLC Sponsored ADR compare | 17.9% |
| TAK Takeda Pharmaceutical Co. compare | 11.6% |
| RDY Dr. Reddy's Laboratories Ltd compare | 10.9% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 8.77% |
| ELAN Elanco Animal Health Incorporated compare | 1.61% |
| VTRS Viatris Inc. | −0.59% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on VTRS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement